{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T12:52:43Z","timestamp":1698238363341},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1991,2,1]],"date-time":"1991-02-01T00:00:00Z","timestamp":665366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1991,2,1]],"date-time":"1991-02-01T00:00:00Z","timestamp":665366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[1991,2]]},"DOI":"10.1007\/bf00194557","type":"journal-article","created":{"date-parts":[[2004,8,27]],"date-time":"2004-08-27T12:09:10Z","timestamp":1093608550000},"page":"97-100","source":"Crossref","is-referenced-by-count":2,"title":["Phase II trial of N-methylformamide in patients with metastatic melanoma"],"prefix":"10.1007","volume":"9","author":[{"given":"Omar","family":"Eton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean F.","family":"Bajorin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ephraim S.","family":"Casper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan N.","family":"Houghton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF00194557_CR1","first-page":"39","volume":"25","author":"ML Schlam","year":"1984","unstructured":"Schlam ML, Pezzella KM, Lockart RZ, Dexter DL: Effects of N-methylformamide on cell cycle, nuclear morphology, and chromatin arrangement in cultured human colon cancer cells. (Abstr) Proc Am Assoc Cancer Res 25: 39, 1984","journal-title":"Proc Am Assoc Cancer Res"},{"key":"BF00194557_CR2","first-page":"532A","volume":"30","author":"DL Dexter","year":"1982","unstructured":"Dexter DL, Spremulli EN, Savarese TM, Diamond I, Calabresi P: Effects of N-methylformamide on murine and human cancer cells. (Abstr) Clin Res 30: 532A, 1982","journal-title":"Clin Res"},{"key":"BF00194557_CR3","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1200\/JCO.1988.6.5.906","volume":"6","author":"K Clagett-Carr","year":"1988","unstructured":"Clagett-Carr K, Sarosy G, Plowman J, Hoth DF, Leyland-Jones B: N-methylformamide: cytotoxic, radiosensitizer, or chemosensitizer. J Clin Onc 6: 906\u2013918, 1988","journal-title":"J Clin Onc"},{"key":"BF00194557_CR4","first-page":"607","volume":"68","author":"JG McVie","year":"1984","unstructured":"McVie JG, Ten Bokkel Huinink WW, Simonetti G, Dubbelman R: Phase I trial of N-methylformamide. Cancer Treat Rep 68: 607\u2013610, 1984","journal-title":"Cancer Treat Rep"},{"key":"BF00194557_CR5","first-page":"881","volume":"70","author":"EA Eisenhauer","year":"1986","unstructured":"Eisenhauer EA, Weinerman BH, Kerr I, Quirt I: Toxicity of oral N-methylformamide in three phase II trials: a report from the National Cancer Institute of Canada Clinical Trials Group. Cancer Treat Rep 70: 881\u2013883, 1986","journal-title":"Cancer Treat Rep"},{"key":"BF00194557_CR6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","volume":"47","author":"AB Miller","year":"1981","unstructured":"Miller AB, Hoogstraten B, Staquet M, Winkler A: Reporting results of cancer treatment. Cancer 47: 207\u2013214, 1981","journal-title":"Cancer"},{"key":"BF00194557_CR7","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/jnci\/80.9.671","volume":"80","author":"EK Rowinsky","year":"1988","unstructured":"Rowinsky EK, Noe DA, Orr DW, Grochow LB, Ettinger DS, Donehower RC: Clinical pharmacology of oral and i.v. N-methylformamide: a pharmacologic basis for lack of clinical antineoplastic activity. J Natl Cancer Inst 80: 671\u2013678, 1988","journal-title":"J Natl Cancer Inst"},{"key":"BF00194557_CR8","first-page":"681","volume":"70","author":"C Sternberg","year":"1986","unstructured":"Sternberg C, Yagoda A, Scher H, Hollander P: Phase II trial of N-methylformamide for advanced renal cell carcinoma. Cancer Treat Rep 70: 681\u2013682, 1986","journal-title":"Cancer Treat Rep"},{"key":"BF00194557_CR9","first-page":"7304","volume":"48","author":"CW Young","year":"1988","unstructured":"Young CW, Fanucchi MP, Declan-Walsh T, Baltzer L, Yaldaei S, Stevens YW, Gordon C, Tong W, Rifkind RA, Marks PA: Phase I trial and clinical pharmacological evaluation of hexamethylene bisacetamide administration by ten-day continuous intravenous infusion at twenty-eight-day intervals. Cancer Res 48: 7304\u20137309, 1988","journal-title":"Cancer Res"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00194557.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF00194557\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00194557","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00194557.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T03:21:54Z","timestamp":1678504914000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF00194557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,2]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1991,2]]}},"alternative-id":["BF00194557"],"URL":"https:\/\/doi.org\/10.1007\/bf00194557","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,2]]}}}